Infinity Pharma’s Cancer Drug Fails Mid-Stage Trial Goals

Infinity Pharmaceuticals’ cancer drug retaspimycin HCl failed to meet its goal of prolonging survival in patients with a type of lung cancer closely linked to smoking.
Reuters